Related Experiment Video
Updated: Mar 20, 2026

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
Development of a World Federation of Hemophilia External Quality Assessment Scheme: results of a pilot study
I Jennings1, S Kitchen1, T A Woods1
1UK NEQAS for Blood Coagulation, Royal Hallamshire Hospital, Sheffield I. Jennings, B.Sc., M.Phil., F.I.B.M.S., Deputy Manager, UK NEQAS for Blood Coagulation, Room E24, E Floor, CSUH, Royal Hallamshire Hospital, Sheffield S10 2JF.*S. Kitchen, F.I.B.M.S., Laboratory Scientist, UK NEQAS for Blood Coagulation, Sheffield.T. A. L. Woods, F.I.B.M.S., Scheme Manager, UK NEQAS for Blood Coagulation, Sheffield.F. E. Preston, M.D., F.R.C.P., F.R.C.Path., Director, UK NEQAS for Blood Coagulation, Sheffield.
Abstract:
A World Federation of Hemophilia External Quality Assessment Scheme has been established to promote high standards of laboratory performance in haemophilia centres worldwide. Twenty-two International Haemophilia Training Centres (IHTCs) participated in a pilot study designed to assess between-laboratory agreement and to establish target values for the prothrombin time, activated partial thromboplastin time, factor VIII:C, IX:C and von Willebrand factor assays. Although variations in results and clinical interpretations were observed between the centres, median results and assay precision were comparable to that seen in the United Kingdom National External Quality Assessment Scheme. IHTC-generated median results were therefore considered appropriate target values against which to compare the performance of haemophilia centres in developing countries.
More Related Videos
06:59The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy